Preliminary study on effective dose of patients in SPECT/CT fusion imaging
- 1. Department of Nuclear Medicine, Tianjin Third Central Hospital, Tianjin (China)
Description
Objective: To assess the patient effective dose during SPECT/CT imaging. Methods: A total of 157 patients (85 males, 72 females; mean age: (60.46 ± 13.44) years, range: 24-88 years) who underwent SPECT/CT from April 2013 to September 2014 were retrospectively analyzed. They were divided into 3 groups: 99Tcm-MDP bone scan group (n = 113), 99Tcm-MIBI parathyroid imaging group (n = 23) and 99Tcm-MAA pulmonary perfusion imaging group (n = 21). The injection dose (MBq) was recorded and the effective dose (mSv) was estimated according to the International Commission on Radiological Protection (ICRP) guideline. The volume-weighted computed tomography dose index (CTDIvol) and dose length product (DLP) of CT were also recorded and the effective dose (mSv) due to CT was calculated. The effective doses among different groups were statistically compared by Kruskal-Wallis rank sum test and Wilcoxon rank sum test. Results: The effective dose from radiopharmaceuticals were (4.02 ± 0.35) mSv for 99Tcm-MDP bone scan, (6.13 ± 0.53) mSv for 99Tcm-MIBI parathyroici imaging and (1.66 ± 0.13) mSv for 99Tcm-MAA pulmonary perfusion imaging (χ2 = 96.853; Z =1.533, 7.262 and 5.676; all P < 0.05). The effective dose due to CT were (3.84 ± 1.98), (1.04 ± 0.19), (4.05 ± 0.47) mSv respectively (χ2 = 41.225, P < 0.05), and there were significant differences between 99Tcm-MIBI parathyroid imaging group and 99Tcm-MDP bone scan group, 99Tcm-MAA pulmonary perfusion imaging group(Z = 6.046 and 5.672, both P < 0.05), The total effective dose during SPECT/CT imaging were (7.86 ± 1.98), (7.21 ± 0.81) and (5.71 ± 0.45) mSv (χ2 = 28.988, P < 0.05). There were significant differences between 99Tcm-MAA pulmonary perfusion imaging group and 99Tcm-MDP bone scan group, 99Tcm-MIBI parathyroid imaging group(Z = 4.967 and 4.994, both P < 0.05). Conclusions: The increase in effective dose due to spiral CT during SPECT/CT examination should be concerned. Appropriate utilization and optimization of SPECT/CT is needed. (authors)
Additional details
Identifiers
Publishing Information
- Journal Title
- Chinese Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 35
- Journal Issue
- 5
- Journal Page Range
- p. 387-390
- ISSN
- 2095-2848
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 53047265
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COMPARATIVE EVALUATIONS; EFFECTIVE RADIATION DOSES; IMAGES; INFUSION; OPTIMIZATION; PATIENTS; RADIATION PROTECTION; RADIOPHARMACEUTICALS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TECHNETIUM 99
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DOSES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; HOURS LIVING RADIOISOTOPES; INTAKE; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; NUCLEI; ODD-EVEN NUCLEI; RADIATION DOSES; RADIOACTIVE MATERIALS; RADIOISOTOPES; TECHNETIUM ISOTOPES; TOMOGRAPHY; YEARS LIVING RADIOISOTOPES
Optional Information
- Notes
- 2 tabs., 11 refs.; http://dx.doi.org/10.3760/cma.j.issn.2095-2848.2015.05.012